Shopify, Inc. (NYSE:SHOP) Q4 2019 Earnings Conference Call February 12, 2020 Company Participants Katie Keita – Senior Director, IR Harley Finkelstein – COO Amy Shapero – […]
Under Armour, Inc. (NYSE: UAA) Q4 2019 Earnings Conference Call February 11, 2020 Company Participants Lance Allega – SVP, IR & Corporate Development Patrik Frisk – CEO Dave Bergman – CFO […]
Kering SA (OTC:PPRUY) Q4 2019 Earnings Conference Call February 12, 2020 Company Participants Jean-Marc Duplaix – CFO François-Henri Pinault – Chairman & CEO Jean-François Palus – Deputy CEO & Director […]
YETI Holdings, Inc. (NYSE:YETI) Q4 2019 Results Earnings Conference Call February 13, 2020 Company Participants Tom Shaw – Vice President of Investor Relations Matt Reintjes – President and Chief Executive […]
Phunware, Inc. (NASDAQ: PHUN) interview with CEO Alan Knitowski discussing the company’s leadership position in mobile applications. Alan explains Phunware’s unique position at the $500 billion intersection […]
CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, providing an update on the company’s drug development pipeline targeting HIV and cancers, based on CytoDyn’s Leronlimab/PRO 140 platform. […]
Chatham Rock Phosphate Limited (TSX.V: NZP) interview with Chris Castle, CEO discussing the company’s rock phosphate project in New Zealand. Chris explains the unique economics of this project which […]
The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) Interview with CEO, Penny Green. In this follow-up to our December 20, 2018 interview, Penny discusses the company’s progress since […]
GP Solutions, Inc. (OTC: GWPD) Interview with Shannon Illingworth, chairman and founder. Shannon discusses the company’s GrowPod modular farming solution, which uses re-purposed shipping containers, and optimized environmental controls to produce “Organic PLUS” agriculture – which is […]
CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, discussing CytoDyn’s PRO140 monoclonal antibody therapy for HIV and cancer. The company is at a key inflection point, with potential FDA approval for PRO140 for […]
Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams, co-founder, and CEO. In this update to our December 2018 interview, Andy provides an update on the company’s […]
Cobalt27 Capital Corp. (TSX.V: KBLT) (OTC: CBLLF) interview with Anthony Milewski, Chairman & CEO. Cobalt is a key ingredient in electric vehicle, and energy storage batteries. In […]
CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, discussing CytoDyn’s PRO140 monoclonal antibody therapy for HIV and cancer. The company is at a […]
Elixinol Global Limited (ASX: EXL) (OTC: ELLXF) Interview with CEO, Paul Benhaim. We caught up with Paul, at the airport, to discuss Elixinol’s progress in the CBD and […]
FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) CEO Interview with Dr. Raza Bokhari. FSD Pharma is building the worlds largest licensed indoor cannabis growing facility […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
